Vetenskapliga publikationer

Drug survival of anti-TNF agents compared with vedolizumab as a second-line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers.
https://pubmed.ncbi.nlm.nih.gov/33340426/

 

A Novel Method for Quantifying Intestinal Inflammatory Burden in Inflammatory Bowel Disease Using Register Data.
https://pubmed.ncbi.nlm.nih.gov/33116900/

 

Healthcare use, work loss and total costs in incident and prevalent Crohn’s disease and ulcerative colitis: results from a nationwide study in Sweden.
https://pubmed.ncbi.nlm.nih.gov/32902894/

 

The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register.
https://pubmed.ncbi.nlm.nih.gov/32370571/

 

Work Loss in Relation to Pharmacological and Surgical Treatment for Crohn’s Disease: A Population-Based Cohort Study.
https://pubmed.ncbi.nlm.nih.gov/32210631/

 

Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register – a validation study.

https://pubmed.ncbi.nlm.nih.gov/33632044/

 

Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG).
https://www.ncbi.nlm.nih.gov/pubmed/27797278

 

Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
https://www.ncbi.nlm.nih.gov/pubmed/28362144

 

Swedish Inflammatory Bowel Disease Register (SWIBREG) – a nationwide quality register.
https://www.ncbi.nlm.nih.gov/pubmed/31498717

 

Clinical effectiveness of golimumab in Crohn’s disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).
https://www.ncbi.nlm.nih.gov/pubmed/30353751

 

Sick leave and disability pension in prevalent patients with Crohn’s disease.
https://www.ncbi.nlm.nih.gov/pubmed/30165593

 

Work Loss Before and After Diagnosis of Crohn’s Disease.
https://www.ncbi.nlm.nih.gov/pubmed/30551185

 

Validating surgical procedure codes for inflammatory bowel disease in the Swedish National PatientRegister.
https://www.ncbi.nlm.nih.gov/pubmed/31711471

 

Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
https://www.ncbi.nlm.nih.gov/pubmed/29102619